DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms

Journal Article · · Breast Cancer Research
 [1];  [2];  [3];  [3];  [3];  [3];  [3];  [3];  [3];  [3]
  1. Univ. of Connecticut, Farmington, CT (United States). Health Center; North Carolina State Univ., Raleigh, NC (United States); DOE/OSTI
  2. Univ. of Connecticut, Farmington, CT (United States). Health Center; Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
  3. Univ. of Connecticut, Farmington, CT (United States). Health Center

Background: Duodenal cytochrome b (DCYTB) is a ferrireductase that functions together with divalent metal transporter 1 (DMT1) to mediate dietary iron reduction and uptake in the duodenum. DCYTB is also a member of a 16-gene iron regulatory gene signature (IRGS) that predicts metastasis-free survival in breast cancer patients. To better understand the relationship between DCYTB and breast cancer, we explored in detail the prognostic significance and molecular function of DCYTB in breast cancer. Methods: The prognostic significance of DCYTB expression was evaluated using publicly available microarray data. Signaling Pathway Impact Analysis (SPIA) of microarray data was used to identify potential novel functions of DCYTB. The role of DCYTB was assessed using immunohistochemistry and measurements of iron uptake, iron metabolism, and FAK signaling. Results: High DCYTB expression was associated with prolonged survival in two large independent cohorts, together totaling 1610 patients (cohort #1, p = 1.6e-11, n = 741; cohort #2, p = 1.2e-05, n = 869; log-rank test) as well as in the Gene expression-based Outcome for Breast cancer Online (GOBO) cohort (p < 1.0e-05, n = 1379). High DCYTB expression was also associated with increased survival in homogeneously treated groups of patients who received either tamoxifen or chemotherapy. Immunohistochemistry revealed that DCYTB is localized on the plasma membrane of breast epithelial cells, and that expression is dramatically reduced in high-grade tumors. Surprisingly, neither overexpression nor knockdown of DCYTB affected levels of ferritin H, transferrin receptor, labile iron or total cellular iron in breast cancer cells. Because SPIA pathway analysis of patient microarray data revealed an association between DCYTB and the focal adhesion pathway, we examined the influence of DCYTB on FAK activation in breast cancer cells. These experiments reveal that DCYTB reduces adhesion and activation of focal adhesion kinase (FAK) and its adapter protein paxillin. Conclusions: DCYTB is an important predictor of outcome and is associated with response to therapy in breast cancer patients. DCYTB does not affect intracellular iron in breast cancer cells. Instead, DCYTB may retard cancer progression by reducing activation of FAK, a kinase that plays a central role in tumor cell adhesion and metastasis.

Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE; National Institute of Dental and Craniofacial Research (NIDCR); National Cancer Institute (NCI); National Institutes of Health (NIH)
Grant/Contract Number:
AC52-06NA25396
OSTI ID:
1626928
Journal Information:
Breast Cancer Research, Journal Name: Breast Cancer Research Journal Issue: 1 Vol. 19; ISSN 1465-542X
Publisher:
BioMed CentralCopyright Statement
Country of Publication:
United States
Language:
English

References (145)

Hepcidin Regulation in Prostate and Its Disruption in Prostate Cancer journal April 2015
Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer journal June 2007
Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis journal June 2013
An Iron Regulatory Gene Signature Predicts Outcome in Breast Cancer journal August 2011
Modulation of iron transport proteins in human colorectal carcinogenesis journal October 2006
Disordered signaling governing ferroportin transcription favors breast cancer growth journal January 2015
Luminal Iron Levels Govern Intestinal Tumorigenesis after Apc Loss In Vivo journal August 2012
Molecular Profiling of Breast Cancer journal July 2014
Dcytb (Cybrd1) functions as both a ferric and a cupric reductase in vitro journal May 2008
Decreased Cancer Risk After Iron Reduction in Patients With Peripheral Arterial Disease: Results From a Randomized Trial journal July 2008
Transcriptional Profiling of Estrogen-Regulated Gene Expression via Estrogen Receptor (ER) α or ERβ in Human Osteosarcoma Cells: Distinct and Common Target Genes for These Receptors journal July 2004
An Iron-Regulated Ferric Reductase Associated with the Absorption of Dietary Iron journal February 2001
Cancer risk following primary hemochromatosis: A population-based cohort study in Denmark journal January 1995
Cancer risk following primary hemochromatosis: A population-based cohort study in Denmark journal January 1995
Activation of Transferrin Receptor 1 by c-Myc Enhances Cellular Proliferation and Tumorigenesis journal March 2006
Functional characterization of human duodenal cytochrome b (Cybrd1): Redox properties in relation to iron and ascorbate metabolism journal March 2008
Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy journal December 2015
A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer journal May 2011
Modeling Survival Data: Extending the Cox Model book January 2000
The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases journal November 2015
A Novel Duodenal Iron-Regulated Transporter, IREG1, Implicated in the Basolateral Transfer of Iron to the Circulation journal February 2000
Overexpression of Cellular Iron Import Proteins Is Associated with Malignant Progression of Esophageal Adenocarcinoma journal January 2008
A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer journal May 2011
Adjusting batch effects in microarray expression data using empirical Bayes methods journal April 2006
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen journal February 2009
Transcriptional Profiling of Estrogen-Regulated Gene Expression via Estrogen Receptor (ER) α or ERβ in Human Osteosarcoma Cells: Distinct and Common Target Genes for These Receptors journal July 2004
Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer journal January 2010
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes journal March 2009
Cloning and characterization of a mammalian proton-coupled metal-ion transporter journal July 1997
FAK phosphorylation at Tyr-925 regulates cross-talk between focal adhesion turnover and cell protrusion journal April 2011
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes journal March 2009
Donation Frequency, Iron Loss, and Risk of Cancer Among Blood Donors journal April 2008
DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms collection January 2017
Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis journal June 2013
Cytochromes b 561: Ascorbate-Mediated Trans-Membrane Electron Transport journal September 2013
Fenton Reaction Induced Cancer in Wild Type Rats Recapitulates Genomic Alterations Observed in Human Cancer journal August 2012
Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas journal March 2003
Nrf2 Mediates the Induction of Ferritin H in Response to Xenobiotics and Cancer Chemopreventive Dithiolethiones journal November 2002
Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives journal December 2003
A novel signaling pathway impact analysis journal November 2008
GOBO: Gene Expression-Based Outcome for Breast Cancer Online journal March 2011
Human Erythrocyte Membranes Contain a Cytochrome b 561 That May Be Involved in Extracellular Ascorbate Recycling journal October 2006
Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives journal December 2003
Breast cancer prognostic classification in the molecular era: the role of histological grade journal July 2010
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization journal December 2004
Mechanisms of heme iron absorption: Current questions and controversies journal January 2008
Focal adhesion kinase: in command and control of cell motility journal January 2005
IRP2 Regulates Breast Tumor Growth journal November 2013
Molecular portraits of human breast tumours text January 2000
An Iron-Regulated Ferric Reductase Associated with the Absorption of Dietary Iron journal February 2001
Coordinated Regulation of Iron-Controlling Genes, H-Ferritin and IRP2 , by c-MYC journal January 1999
Increasing Precision in Adjuvant Therapy for Breast Cancer journal August 2016
Donation Frequency, Iron Loss, and Risk of Cancer Among Blood Donors journal April 2008
A Novel Duodenal Iron-Regulated Transporter, IREG1, Implicated in the Basolateral Transfer of Iron to the Circulation journal February 2000
Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis journal August 2010
Molecular portraits of human breast tumours journal August 2000
Coordinated Regulation of Iron-Controlling Genes, H-Ferritin and IRP2 , by c-MYC journal January 1999
Iron enhances tumor growth. Observation on spontaneous mammary tumors in mice journal December 1991
Adjuvant Therapy in Stage I Carcinoma of the Breast: The Influence of Multigene Analyses and Molecular Phenotyping: Adjuvant Therapy in Stage I Breast Cancer journal July 2012
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress journal September 2022
Iron and Colorectal Cancer Risk: Human Studies journal May 2001
Analysis of genes implicated in iron regulation in individuals presenting with primary iron overload journal August 2004
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository journal January 2002
Nrf2 Mediates the Induction of Ferritin H in Response to Xenobiotics and Cancer Chemopreventive Dithiolethiones journal November 2002
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes text January 2009
Focal adhesion kinase: in command and control of cell motility journal January 2005
Activation of Transferrin Receptor 1 by c-Myc Enhances Cellular Proliferation and Tumorigenesis journal March 2006
An Iron Delivery Pathway Mediated by a Lipocalin journal November 2002
Mechanisms of heme iron absorption: Current questions and controversies journal January 2008
Cloning and characterization of a mammalian proton-coupled metal-ion transporter journal July 1997
Regulation of the Cell Cycle by Focal Adhesion Kinase journal December 1998
Cytochrome b561 catalyzes transmembrane electron transfer. journal July 1984
Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis journal November 2004
Yin Yang 1 regulates the transcriptional activity of androgen receptor journal August 2009
GOBO: Gene Expression-Based Outcome for Breast Cancer Online journal March 2011
HFE C282Y homozygotes are at increased risk of breast and colorectal cancer journal November 2009
Standardized versus research-based PAM50 intrinsic subtyping of breast cancer text January 2020
limma powers differential expression analyses for RNA-sequencing and microarray studies journal January 2015
Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer journal January 2010
Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation journal May 1988
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study text January 2016
Yin Yang 1 regulates the transcriptional activity of androgen receptor journal August 2009
Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy text January 2015
Molecular and Functional Roles of Duodenal Cytochrome B (Dcytb) in Iron Metabolism journal November 2002
Temporal changes in the gene expression heterogeneity during brain development and aging journal March 2020
Genetic Variability in Iron-Related Oxidative Stress Pathways (Nrf2, NQ01, NOS3, and HO-1), Iron Intake, and Risk of Postmenopausal Breast Cancer journal September 2007
Overexpression of Cellular Iron Import Proteins Is Associated with Malignant Progression of Esophageal Adenocarcinoma journal January 2008
Excess Capacity of the Iron Regulatory Protein System journal June 2007
Analysis of genes implicated in iron regulation in individuals presenting with primary iron overload journal August 2004
Modulation of iron transport proteins in human colorectal carcinogenesis journal October 2006
Disordered signaling governing ferroportin transcription favors breast cancer growth journal January 2015
A cis-acting element is necessary and sufficient for translational regulation of human ferritin expression in response to iron. journal October 1987
Dcytb (Cybrd1) functions as both a ferric and a cupric reductase in vitro journal May 2008
Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas journal March 2003
An ascorbate-reducible cytochrome b561 is localized in macrophage lysosomes journal December 2006
Using High-Throughput Transcriptomic Data for Prognosis: A Critical Overview and Perspectives journal September 2014
An iron regulatory gene signature in breast cancer: more than a prognostic genetic profile? journal February 2012
Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis journal November 2004
FAK in cancer: mechanistic findings and clinical applications journal August 2014
Human Erythrocyte Membranes Contain a Cytochrome b 561 That May Be Involved in Extracellular Ascorbate Recycling journal October 2006
Duodenal cytochrome b : a novel ferrireductase in airway epithelial cells journal August 2006
Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy collection January 2015
Gene-expression profiling in breast cancer journal February 2005
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications journal September 2001
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study journal February 2016
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer journal August 2016
Molecular Profiling of Breast Cancer journal July 2014
Optimal Statistical Incorporation of Independent Feature Stability Information into Radiomics Studies journal January 2020
Binding and uptake of H-ferritin are mediated by human transferrin receptor-1 journal February 2010
Excess Capacity of the Iron Regulatory Protein System journal June 2007
Duodenal cytochrome b : a novel ferrireductase in airway epithelial cells journal August 2006
Genetic Variability in Iron-Related Oxidative Stress Pathways (Nrf2, NQ01, NOS3, and HO-1), Iron Intake, and Risk of Postmenopausal Breast Cancer journal September 2007
Luminal Iron Levels Govern Intestinal Tumorigenesis after Apc Loss In Vivo journal August 2012
Binding and uptake of H-ferritin are mediated by human transferrin receptor-1 journal February 2010
Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia journal June 2020
Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation journal May 1988
Iron and Colorectal Cancer Risk: Human Studies journal May 2001
Modeling Survival Data: Extending the Cox Model journal February 2002
An Iron Delivery Pathway Mediated by a Lipocalin journal November 2002
A cis-acting element is necessary and sufficient for translational regulation of human ferritin expression in response to iron. journal October 1987
Functional characterization of human duodenal cytochrome b (Cybrd1): Redox properties in relation to iron and ascorbate metabolism journal March 2008
Fenton Reaction Induced Cancer in Wild Type Rats Recapitulates Genomic Alterations Observed in Human Cancer journal August 2012
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications text January 2001
Fiji: an open-source platform for biological-image analysis journal June 2012
limma powers differential expression analyses for RNA-sequencing and microarray studies text January 2015
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer journal February 2005
Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis journal August 2010
Adjuvant Therapy in Stage I Carcinoma of the Breast: The Influence of Multigene Analyses and Molecular Phenotyping: Adjuvant Therapy in Stage I Breast Cancer journal July 2012
HFE C282Y homozygotes are at increased risk of breast and colorectal cancer journal November 2009
Lipocalin 2 is required for BCR-ABL-induced tumorigenesis journal July 2008
FAK phosphorylation at Tyr-925 regulates cross-talk between focal adhesion turnover and cell protrusion journal April 2011
Cytochromes b 561: Ascorbate-Mediated Trans-Membrane Electron Transport journal September 2013
Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer journal June 2007
Mycobacterial HelD is a nucleic acids-clearing factor for RNA polymerase posted_content July 2020
Hepcidin Regulation in Prostate and Its Disruption in Prostate Cancer journal April 2015
Luminal Iron Levels Govern Intestinal Tumorigenesis after Apc Loss In Vivo journal December 2016
Iron regulates ferritin mRNA translation through a segment of its 5' untranslated region. journal December 1987
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications journal September 2001
Using High-Throughput Transcriptomic Data for Prognosis: A Critical Overview and Perspectives journal September 2014
Quantifying chromogen intensity in immunohistochemistry via reciprocal intensity. journal December 2013
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization journal December 2004
Decreased Cancer Risk After Iron Reduction in Patients With Peripheral Arterial Disease: Results From a Randomized Trial journal July 2008
affy--analysis of Affymetrix GeneChip data at the probe level journal February 2004
Cytochrome b561 protein family: Expanding roles and versatile transmembrane electron transfer abilities as predicted by a new classification system and protein sequence motif analyses journal December 2005
Molecular and Functional Roles of Duodenal Cytochrome B (Dcytb) in Iron Metabolism journal November 2002

Cited By (5)

Long Non-Coding RNA (LncRNA) HOXA11-AS Promotes Breast Cancer Invasion and Metastasis by Regulating Epithelial-Mesenchymal Transition journal July 2017
LncRNAs Predicted to Interfere With the Gene Regulation Activity of miR-637 and miR-196a-5p in GBM journal March 2020
Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer journal May 2018
NEAT1 contributes to breast cancer progression through modulating miR-448 and ZEB1 journal May 2018
Long intergenic noncoding RNA 00641 inhibits breast cancer cell proliferation, migration, and invasion by sponging miR‐194‐5p journal September 2019